Puff, vapotage et médecines alternatives permettent-ils de réduire ou de stopper sa consommation de tabac?
🔊smartlink.ausha.co/hugpodcast/l-e… Oncology Division - Geneva University Hospital Alfredo Addeo MD #tabac #puff #santé

Donal Hollywood award winner at #ESTRO24
Piet Ost for the STORM trial
Congrats to Thomas Zilli and all contributors 👏

#RomeLung24

The IASLC #WCLC25 co-chairs are together in Rome…planning, chatting & getting ideas from Federico Cappuzzo

Great to have committed minds pushing each other to ask & answer the important questions

Beaumont RCSI Cancer Centre Noemi Reguart Isabelle Opitz Umberto Malapelle #LCSM

Honored to join Vinay Prasad Vinay Prasad MD MPH in the 'Drug Development Letter'

Subscribe and stay tuned for even more content !

Thanks Alessandro Gronchi and the investigators for providing important insights.

Check out the full correspondence :
ascopubs.org/doi/10.1200/JC…

+ their nice conclusion 👇
2/2

Just out in Journal of Clinical Oncology, led by Dr Brian Schulte UC San Francisco with Pr Nicolas Mach HUG,

➡️we corresponded with Alessandro Gronchi after the publication of the ISG-STS 1001 study in Myxoid Liposarcoma 👇
1/2

New in Perspectives:

Quackery - The fate of #sotorasib : a regulatory failure potentially harming patients thelancet.com/journals/lanon…

ESMO - Eur. Oncology is looking for an editor-in-chief for the newly journal ESMO Rare Cancers. More info at:

esmo.org/about-esmo/org…

Clinical Research Team brings phase one trials to patients in Lincolnshire lincolnshireworld.com/news/clinical-…

Check out our work led by Sruthi Ranganathan , with Vinay Prasad MD MPH 👇
Out today in The Lancet Oncology !

🔥NEOpredict-Lung: Neoadjuvant nivolumab with or without relatlimab (anti-LAG-3) in resectable NSCLC
🎙️Dr. Martin Schuler Nature Medicine
🎯DFS%12mo: 93% in combination
✅Phase II
✅Primary: Feasibility of surgery
✅NCT04205552
#LCSM OncoAlert
nature.com/articles/s4159…

Cette étude sur les mutations EGFR rares rencontrées dans les cancers du poumon à non petites cellules montre qu’il existe des solutions thérapeutiques: jto.org/article/S1556-… Timothée Olivier, MD Alfredo Addeo MD Oncology Division - Geneva University Hospital MD Anderson Cancer Center University of Portsmouth Mayo Clinic #oncologie #recherche

We are launching the ESMO Virtual Journal Club!!! esmo.org/about-esmo-mee…

#ASCO24 Lung cancer is not just invading the plenaries...but other tracks as well!

Looking forward to discussing 2 NSCLC abstracts in the
CNS orals:
- High-dose almonertinib in EGFR+ NSCLC with CNS mets
- Ph III METIS trial: TTF in NSCLC brain mets

ASCO Beaumont RCSI Cancer Centre #LCSM

The 7th National Hellenic oncology Congress ΕΟΠΕ just began , all of us and our special distinguished guest expert and amazing person Charu Aggarwal, MD, MPH, FASCO are looking forward to welcome all of you!! #some #lcsm
Marita Lykka MD ESMO - Eur. Oncology IASLC ASCO OncoAlert

IASLC Members We Need Your Opinion! Dr. Narjust Florez, MD, FASCO encourages all of us to help shape the IASLC community by taking our 5-min survey in multiple languages to help us understand diverse needs & enhance initiatives. Let's build inclusivity together! gather.video/h7wo

Results of phase III RESILIENT study of liposomal irinotecan vs topotecan in pts with relapsed #SCLC (n=461) Journal of Clinical Oncology. Higher RR (44% vs 22%) but did not improve OS (7.9m vs 8.3m, HR 1.11) or PFS (4.0m vs 3.3m, HR 0.96). Fewer G3+ TEAEs (42% vs 83%).

ascopubs.org/doi/10.1200/JC…

Ooh, love the title “Are we on BEAT” discussed by Melina Marmarelis ! This will be a great session #ASCO24

Check out the latest work of Prof. Alfredo Addeo Alfredo Addeo MD and colleagues published in JAMA Network Open on neoadjuvant chemoimmunotherapy for early NSCLC HUG Université de Genève
👉

New #OpenAccess study suggest that neoadjuvant platinum-based ICI-chemo. for those with early-stage #NSCLC is associated with improvements in 2-year EFS and pCR 🫁

See the full study in JAMA Network Open by Giuseppe Banna, Mona Hassan, Alfredo Addeo MD & colleagues ⬇️

jamanetwork.com/journals/jaman…